IB WCS 44
LABORATORY INVESTIGATIONS
Prof VNY Chan
Medicine
Thu 10-10-02
OBJECTIVES
LAB MEDICINE
MAIN USES OF CLINICAL BIOCHEM RESULTS
LAB RESULTS MOSTLY CONTAIN NUMERICAL, QUANTITATIVE MEASURES
1. Units
2. Normal vs. abnormal
SEE GRAPH
THE ASSESSMENT OF DIAGNOSTIC TESTS
To evaluate/ interpret a test it is necessary to know how it behaves in health and disease
1. Sensitivity (true-positive rate). This is the incidence (per cent) of positive results for a test in patients with the particular disease. A test which is always abnormal (or positive) in patients with the disease has 100% sensitivity. If there is overlap between healthy + diseased, it is not 100% [how accurately it picks up the abnormals]
2. False-positive rate. This is the incidence (per cent) of positive results in people known or subsequently proved to be free from the particular disease. If a test is always normal in individuals who do not have the disease, that test has a false-positive rate of 0%. 100 - false positive rate = specificity
Predictive rate of a +ve result = (+ve result + diseased) / (+ve result + no disease) x 100
3. The predictive value of a positive test result. This is the percentage of positive results that are true positives when a test is performed on a defined population containing both healthy and diseased individuals.
CARDIAC & SKELETAL MUSCLE
1. Normal muscle contains: Mb, Troponin, CK, Myosin, Actin, AST, LDH
2. Relative ability of tests to detect MI (sensitivity)
Test |
Size of MI (unit?) |
Troponin |
0.001 |
CK-Mb |
0.01 |
CK or AST |
0.1 |
ECHO |
10 |
ECG |
10 |
3. Relative performance of laboratory markers of myocardial damage with time
|
1st detected (hr) |
Rel |
Dur (hr) |
Sensitivity for MI Q / non-Q |
Sensitivity for unstable angina (%) |
Mb |
2-3 |
12 |
18-24 |
100 / 100 |
? |
Troponin I (specific) |
4-6 |
50 |
> 144 |
100 / 100 |
20 |
Troponin T |
3-4 |
50 |
> 240 |
100 / 100 |
40 |
CK |
6-8 |
8 |
36-48 |
100 / 80 |
0 |
CK-Mb mass isoforms |
3-4 |
12 |
24-36 |
100 / 100 |
25 |
AST |
8-10 |
5 |
36-60 |
100 / 90 |
0 |
LDH |
12-14 |
2.5 |
96-160 |
80 / 30 |
0 |
4. CK
Dimer Isoforms Myocardium Skeletal M
CK ® M (muscle) ® MM ® 85-90% ® 98%
® B (brain) ® MB ® 10-15% ® 2%
ALKALINE PHOSPHATASE LEVELS RELATED TO AGE
|
U / L |
Newborn |
60-250 |
1-3 yo |
120-350 |
3-10 yo |
120-320 |
10-16 yo |
80-280 |
Adult male |
49-138 |
Adult female |
34-104 |
Found: liver dysfunction and bone metabolism
Also: Serum ferritin (upper limit)
TESTS FOR ORGAN FUNCTION & DISEASE
LIVER FUNCTION TESTS
1. Detoxification & excretory functions
a) Bilirubin
(i) Indirect (85%, water-insoluble): unconjugated; increased haemolysis
(ii) Direct (15%, water-soluble): conjugated; increased in liver + biliary dis
b) Ammonia (NH3). Increase in severe hepatocellular disease + portal HT [Ammonia detoxified to urea in liver]
2. Biosynthetic function
a) Serum albumin
® ¯ albumin in chronically ill, liver disease, malnutrition (eg. Elderly)b) Coagulation factors: II, V, VII, IX & X (also VIII)
3. Detect injury to liver cells (enzyme tests)
LFT IN DIFFERENTIAL DIAGNOSIS OF CAUSES OF LIVER DAMAGE
HEPATITIS
Features |
Viral |
Alcoholic |
Toxic/ Ischaemic |
AST/ALT ratio at Dx |
<1 |
>2 |
>1 |
Peak AST (x N) |
10-100 |
1-10 |
>100 |
LDH (x N) |
1-2 |
1-2 |
10-40 |
Peak BR (mmol/l) |
85-340 |
51-340 |
<85 |
Prothrombin time |
N |
N or ± |
|
TESTS TO DETECT INJURY TO LIVER CELLS : SERUM ENZYMES
1. Enzymes that reflect damage to hepatocytes
2. Enzymes that reflex cholestasis
LABORATORY TESTS FOR DIAGNOSIS OF SPECIFIC DISEASE
1. Diseases with detectable abnormalities
a) Serum ceruloplasmin decreased in Wilson's Disease
b) Urine phenylalanine present in phenylketonuria (inborn error of metabolism)
c) Red cell G6PD enzyme - decrease in G6PD deficiency
2. Tumour markers
3. Genetic abnormalities in inherited & acquired diseases
TUMOUR MARKERS
MARKER |
TUMOUR |
EARLY DETECTION |
SPECIFICITY |
AFT |
Liver; Germ cell tumours |
Y |
in liver injury (eg. Hep); Foetal distress during preg |
CA125 |
Ovary |
< 50% |
in benign peritoneal dis; Liver disease |
CA19.9 |
Pancreas; Colon; Stomach |
< 50% |
in obstructive jaundice |
CA15.3 (27.29) |
Br |
N |
in liver disease |
CEA * |
GIT; Pancreas; Lung; Br; Uterus |
< 50% |
in liver disease + smoking |
HCG |
Chorionic tumours; Breast |
N |
normal preg |
PSA |
Prostate; Renal |
60% |
in BPH |
* CEA = Carcino embryonic Ag
BEDSIDE OR 'CLINIC' TESTS
1. Urinalysis
2. Blood Tests
a) Glucose
b) Others
GLYCOSURIA
Glucosuria
Glycosuria
PROTEINURIA
Strip test
Confirmation tests
A) Sulphosalicylic acid (20%)
Semiquantitation |
Conc (g/L) |
Appearance |
1+ (+) |
0.3 |
Turbid |
2+ (++) |
1.0 |
Flocculation (mild granules) |
3+ (+++) |
3.0 |
Precipitate |
4+ (++++) |
20+ |
Solid precipitate |
B) Boiling test
STRIP-TESTS - URINE MULTI-TEST
Nitrite: N = -ve (infection)
Urobilinogen: N = not increased (haemolysis, liver dis)
Protein: N = -ve (renal disease)
pH: N = acid (alkaline in veggies + infection)
Blood: N = -ve (haematuria)
Specific Gravity: N = 1.010
Ketone: N = -ve (DM, fasting)
BR: N = -ve (bile duct obstruction)
Glucose: N = -ve (DM, renal)
COLOUR OF URINE
Colour |
Pathological |
Diet & Drugs |
Colourless/ Straw/ Lemon-yellow |
Normal |
Volume |
Deep yellow |
- |
Quinacrine, riboflavin (B1), Tetracycline |
Orange |
- |
Rifampicin, pyridium |
Greenish-brown |
Bile pigment, BR |
- |
Grey/ Brown/ Black |
Melanogen (melanoma), Homogentisic acid, (alkaptonuria) |
Some IV iron *, L-dopa (on standing), Phenacetin |
Pink/red/reddish brown |
Hb, MetHb, Mb, Porphobilinogen, porphyrins, Haematuria |
Beetroot (antroquinone), Laxative (eg. Senna, eosin), Antrayccline drugs (eg. Andriamycin), Phenolphtalein (alkaline urine) |
Greenish blue |
Biliverdin (greenish) |
Indigo blue, methylene blue |
* If Pt on chelating agent, urine should be coloured (excretion of iron in urine)
MICROSCOPIC EXAMINATION OF URINE
1. RBC
Glomerular origin: dysmorphic, due to nephritis (medicine)
Pelvis & Bladder origin: isomorphic (stone in bladder - surgery)
2. WBC
3. CASTS
4. CRYSTALS
5. BACTERIA & OVA
Culture; Schistosoma haematobium
REFERENCES